VERTEX PHARMACEUTICALS INC (VRTX) Institutional Ownership and Insiders Activity
VERTEX PHARMACEUTICALS INC (VRTX) is widely held by institutional investors, with 1776 firms reporting positions valued at approximately $118.05B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Capital World Investors is the largest disclosed holder, reporting approximately $13.58B in VRTX holdings in its latest filing.
Recent insider activity includes 6 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
1,776
Total Reported Value
$118.05B
Largest Holder
Capital World Investors
Largest Position
$13.58B
Insider Transactions (90d)
6
Latest Filing Quarter
Q3 2026
New Institutional Positions
188
Funds Exiting Positions
147
Top Institutional Owners
View all- Capital World Investors$13.58B
- Blackrock, Inc.$12.44B
- Capital Research Global Investors$9.31B
- Vanguard Capital Management Llc$8.68B
- State Street Corp$6.29B
VRTX News
All news- Provident Investment Management Portfolio Changes in Q3 2026
Oct 26, 2026 · valut.ai
- Provident Investment Management Portfolio Changes in Q2 2026
Aug 12, 2026 · valut.ai
Related VRTX Institutional Insights:
- VRTX 13F Institutional Holders
- VRTX Superinvestors
- VRTX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- VRTX Insider Trading & SEC Form 4 Activity
- VRTX Articles
- Top Institutional Investor Stock Rankings